CANCER:

Retinoblastoma

No biomarker No biomarker	Retinoblastoma Retinoblastoma	cyclophosphamide oral Sensitive: A1 - Approval
BRD4 overexpression BRD4 overexpression	Retinoblastoma Retinoblastoma	JQ-1 Sensitive: D – Preclinical
B4GALNT1 expression B4GALNT1 expression	Retinoblastoma Retinoblastoma	CAR-T immunotherapy Sensitive: D – Preclinical
PRMT5 overexpression PRMT5 overexpression	Retinoblastoma Retinoblastoma	EPZ015666 Sensitive: D – Preclinical

Associations(4)